Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2020-02-13 4:18 pm Sale | 13G | ALDER BIOPHARMACEUTICALS INC ALDR | TPG Group Holdings (SBS) Advisors Inc. | 0 0% | -1,238,533 (Position Closed) | View |
2019-10-31 4:27 pm Unchanged | 13G | ALDER BIOPHARMACEUTICALS INC ALDR | DAVIDSON KEMPNER PARTNERS | 0 0% | 0 (Unchanged) | View |
2019-10-24 6:55 pm Purchase | 13D | ALDER BIOPHARMACEUTICALS INC ALDR | H LUNDBECK A S | 101,167,019 100% | 89,567,318 (+772.15%) | View |
2019-10-24 4:28 pm Sale | 13D | ALDER BIOPHARMACEUTICALS INC ALDR | Redmile Group LLC | 25,000 0% | -8,342,616 (-99.70%) | View |
2019-10-10 12:47 pm Sale | 13G | ALDER BIOPHARMACEUTICALS INC ALDR | PRICE T ROWE ASSOCIATES INC | 633,121 0.7% | -7,078,957 (-91.79%) | View |
2019-10-10 12:11 pm Sale | 13G | ALDER BIOPHARMACEUTICALS INC ALDR | WELLINGTON MANAGEMENT GROUP LLP | 79,962 0.1% | -10,258,888 (-99.23%) | View |
2019-09-26 1:26 pm Purchase | 13D | ALDER BIOPHARMACEUTICALS INC ALDR | H LUNDBECK A S | 11,599,701 13.3% | 11,599,701 (New Position) | View |
2019-09-17 4:20 pm Purchase | 13D | ALDER BIOPHARMACEUTICALS INC ALDR | Redmile Group LLC | 8,367,616 9.99% | 54,110 (+0.65%) | View |